Omaxe · NSE: OMAXE · BSE: 532880
Q4 FY25 results · Jan–Mar 2025
Omaxe reported revenue from operations of ₹541.26 crore (up 1.1% from Q4 FY24) and net loss of ₹148.67 crore for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 541.26 | 535.58 | +1.1% | 288.94 | +87.3% |
| Other income | 11.77 | 6.74 | +74.6% | 11.45 | +2.8% |
| Total income | 553.03 | 542.32 | +2.0% | 300.39 | +84.1% |
| Profit before share of associates & JVs and tax | (157.20) | (191.37) | Loss narrowed | (182.68) | Loss narrowed |
| Share of profit/(loss) of associates & JVs | (0.05) | 0.14 | 0.00 | ||
| Net profit for the period | (148.67) | (143.59) | Loss widened | (150.28) | Loss narrowed |
| Attributable to shareholders of the company | (148.32) | (145.05) | Loss widened | (150.59) | Loss narrowed |
| EPS, basic (₹) | (8.11) | (7.93) | Loss widened | (8.23) | Loss narrowed |
| Net margin (%) | -27.5 | -26.8 | -52.0 |
This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 138.17 | 168.55 | −18.0% | 76.03 | +81.7% |
| Other income | 12.30 | 5.38 | +128.6% | 2.03 | +505.9% |
| Total income | 150.47 | 173.93 | −13.5% | 78.06 | +92.8% |
| Profit before tax | (19.88) | (73.06) | Loss narrowed | (51.57) | Loss narrowed |
| Net profit for the period | (20.76) | (52.77) | Loss narrowed | (40.30) | Loss narrowed |
| EPS, basic (₹) | (1.14) | (2.89) | Loss narrowed | (2.20) | Loss narrowed |
| Net margin (%) | -15.0 | -31.3 | -53.0 |
Consolidated
- Filed with BSE
- 28 May 2025, 23:45 IST
- Board meeting
- 28 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 28 May 2025, 23:45 IST
- Board meeting
- 28 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE